Rapport Therapeutics, Inc.
RAPP· Nasdaq
Released Aug 7, 2025, before the open
10-Q filed Aug 7, 2025, 38 days after period end · 0000950170-25-104565
| Metric | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|
| Revenue | $0.00 | — | — |
| Net Income | -$26.73M | -$18.12M | -$6.41M |
| EPS Diluted | -$0.75 | -$1.70 | -$4.45 |
Rapport Therapeutics, Inc. · CIK 2012593 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.